Silverarc Capital Management’s Wave Life Sciences WVE Stock Holding History

Silverarc Capital Management’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,050,374	Closed	-$8.49M	–	87
2025 Q1	$8.49M	Buy	1,050,374 +441,477	+73%	+$4.83M	1.74%	18
2024 Q4	$7.53M	Sell	608,897 -18,655	-3%	-$249K	1.65%	20
2024 Q3	$5.15M	Buy	627,552 +132,081	+27%	+$790K	1.16%	31
2024 Q2	$2.47M	Hold	495,471	–	–	0.58%	49
2024 Q1	$3.06M	Buy	+495,471	New	+$2.48M	0.85%	36
2023 Q1	–	Sell	-50,000	Closed	-$350K	–	103
2022 Q4	$350K	Buy	+50,000	New	+$230K	0.1%	81
2021 Q3	–	Sell	-123,972	Closed	-$826K	–	107
2021 Q2	$826K	Buy	123,972 +83,972	+210%	+$549K	0.37%	68
2021 Q1	$224K	Buy	+40,000	New	+$384K	0.12%	84

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Silverarc Capital Management's WVE Position: Q2 2025 in Review

Silverarc Capital Management sold out of Wave Life Sciences (WVE) in Q2 2025, closing a stake of 1,050,374 shares — an estimated $8.49M sold.

Silverarc Capital Management first reported a position in WVE in Q1 2021 and held it in 8 quarters. The position peaked at $8.49M in Q1 2025. 176 funds tracked by Wall St. Rank hold WVE as of Q2 2025.

Silverarc Capital Management reported no remaining Wave Life Sciences position as of Q2 2025 after selling out during the quarter.
Silverarc Capital Management sold 1,050,374 Wave Life Sciences shares in Q2 2025, an estimated $8.49M.
Silverarc Capital Management first reported a position in Wave Life Sciences in Q1 2021 and held it in 8 quarters.
Silverarc Capital Management's Wave Life Sciences position peaked at $8.49M in Q1 2025.
176 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2025.

Based on Silverarc Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.